
Survey responses were analyzed using Stata, version 13 (StataCorp, College Station, TX) using the χ 2 test for categorical variables and paired t test or Wilcoxon signed-rank tests for continuous variables. A P value of <.05 was deemed statistically significant.Extended β-lactam testing that involved more than just penicillins was less infrequently used Figure 1), and it was more likely to be offered by federal institutions (19%, 6 of 31) than private practice (4%, 7 of 183) (P = .01). Skin prick test/IDT and oral challenge for non-β-lactams was available to 13% (60 of 460) and 30% (141 of 460) of respondents, respectively.
